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Conclusions: For a moving target, it was confirmed that the 4D CBCT 
based registration provided more accuracy compared to 3D CBCT 
based registration. 
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Purpose/Objective: Irradiation of pancreatic tumors requires large 
margins to account for respiratory-induced intrafractional tumor 
motion. These margins are derived from a single pre-treatment 4DCT 
scan. This respiratory-induced intrafractional motion can be visualized 
using implanted fiducial markers. 
The purpose of the current study is to quantify the respiratory-
induced motion of pancreatic cancer, both on the 4DCT scan as well 
as on daily cone beam CT (CBCT) scans during a 5 week course of 
radiation to reveal possible trends during the course of treatment. 
Materials and Methods: Eight patients (4 male / 4 female) with 
borderline resectable pancreatic cancer were treated with 25 x 2Gy 
plus weekly gemcitabine 300 mg/m2. All patients received 2 to 4 
fiducial markers by endoscopic ultrasound-guided implantation. The 
amplitude of respiratory-induced motion was measured on the pre-
treatment 4DCT scan and also on all available daily CBCT scans. Phase 
reconstructions of the CBCT scans were made by an automated 
selection of the 2D projection images corresponding to the peak 
inhale and exhale phases. These reconstructions were matched to the 
(reference) planning CT. The amplitudes (differences between the 2 
extreme positions) were analyzed by matching on the markers (in 
three directions) and on the diaphragm (superior-inferior (SI) direction 
only). Rotations and deformations of the tissue were not analyzed. 
The amplitudes were linearly fit as a function of time (i.e. treatment 
day). The fits were tested for significance using a Student’s t-test and 
statistical significance was assumed at p≤0.05. 
Results: The amplitude of intrafractional motion of the markers was 
greatest in the SI direction (mean 5.9mm, SD: 2.7mm on CBCT). 
Differences up to 5.1mm (range: 0.3 - 5.1 mm) were found between 
the amplitude on the 4DCT scan and the mean amplitude of all CBCT 
scans of a single patient.  
The analysis of daily respiratory-induced motion of the markers 
revealed significant trends in the amplitude as a function of time 
(table and figure). The diaphragm did not always show the same trend 
as the markers. For the markers neither the amplitudes nor the trends 
were significant in the other 2 directions (data not shown). 
Conclusions: The 4DCT used for treatment planning is often not 
representative of the respiratory-induced motion amplitude during 
treatment. The CBCT projection images showed significant time 
trends in the amplitude of respiratory-induced motion during a five 
week course of radiation. These time trends in the amplitudes 
indicate the usefulness of adaptive treatment procedures. 
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Purpose/Objective: Dynamic multi-leaf collimator (DMLC) tracking 
can mitigate the dosimetric impact of target motion during volumetric 
modulated arc therapy (VMAT). However, residual dosimetric errors 
still exist. The purpose of this study was to create a simple model for 
time-resolved reconstruction of the delivered dose distribution and to 
validate its ability to predict the time-resolved dosimetric errors 
measured during VMAT of moving targets with and without DMLC 
tracking. 
Materials and Methods: DMLC tracking experiments were performed 
on a Trilogy linear accelerator (Varian Medical Systems) connected to 
prototype DMLC tracking software. A three-axis motion stage, carrying 
a Delta4 phantom (Scandidos) on a custom built platform, reproduced 
eight representative tumor trajectories; four lung and four prostate. 
For each trajectory, two VMAT treatment plans (low and high 
modulation) were delivered with and without DMLC tracking. During 
tracking the MLC leaves were continuously refitted to the 3D target 
position measured by an electromagnetic RayPilot transponder 
(Micropos Medical) at 30 Hz. Doses were measured with the orthogonal 
detector arrays of the Delta4 phantom at a rate of 72 Hz.  
Offline, the measured doses were down-sampled to steps of 10 dose 
pulses to reduce noise (mean time resolution of 20 Hz). The time-
resolved dose distribution was compared to a reference dose 
measured without target motion by use of time-resolved 3%/3mm γ-
tests with exclusion of detectors receiving less than 5% of the 
maximum dose in the accumulated reference dose. For all 
experiments, the time-resolved dose delivered to each detector in the 
phantom was calculated by a simple model that included the target 
position, the MLC aperture convolved with a 2D dose kernel, the dose 
rate, and a percentage depth dose. Like for the measurements, the 
time-resolved 3%/3mm γ-test was also performed for the 
reconstructed doses by comparison with the reconstructed dose to a 
static phantom. Finally, the reconstructed and the measured γ failure 
rates were compared for each experiment. 
Results: 
 
Fig. A compares the measured and reconstructed transient and 
cumulative doses for a single detector during beam delivery in one 
experiment. The scatter plots in Fig. B compare the measured and 
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reconstructed γ-test failure rates of all experiments. The 
reconstructed γ-test failure rates were in excellent agreement with 
the measurements for both the transient dose (left) and the final 
accumulated dose (right). 
Conclusions: A simple time-resolved dose delivery reconstruction 
model was created and its ability to predict dose delivery errors was 
validated experimentally for VMAT treatments with and without DMLC 
tracking. The time-resolved reconstruction allows temporal and 
spatial pinpointing of errors in the dose delivered to moving targets. 
With an online implementation, it may be used for treatment 
intervention in case of erroneous dose evolvement in tracking and 
non-tracking treatments.  
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Purpose/Objective: A convolution-based dose reconstruction 
including intra-fraction residual tumor motion to evaluate dose 
coverage of the gross target volume (GTV) after tumour tracking.  
Materials and Methods: 7 patients were treated with dynamic tumor 
tracking (DTT) on the Vero SBRT system (2 NSCLC and 5 liver/lung 
oligometastases).  
For NSCLC, dose was prescribed to the 95% isodose on the PTV 
perifery, while for lung/liver metastases the dose was prescribed to 
the 80% isodose on the PTV perifery with an intend to boost 60% of the 
GTV to obtain a BED > 100. 
The stable exhale phase of the 4DCT was selected for target 
delineation and DTT treatment planning. An isotropic margin of 5 mm 
was added to the GTV volume to accomodate targeting uncertainty. 
The static dose was calculated with iPlan XVMC. 
DTT on Vero SBRT was performed by a correlation model between skin 
markers and the internal target position. During DTT, the gimballed 
linac compensated for beams-eye view (BEV) target motion while 
ignoring target motion parallel to the beam central-axis (CAX). The 
prediction of the correlation model for the target position was 
verified by 0.5 Hz orthogonal X-ray imaging.  
After DTT treatment, 95th percentiles of respectively tracking errors 
(TE) in the BEV (E95BEV) and 3D displacement of target centroid around 
the tracking beam isocenter (E953D) were calculated. The tumour 
positions were reconstructed from orthogonal imaging, while the 
tracking isocenter was retreived from the gimbals position log file. 
A convolution of the static dose with the 3D probability density 
function (PDF), based on E953D, was performed to reconstruct the 
delivered dose under influence of DTT (see figure 1). The 
reconstructed DTT dose to the GTVDT was compared with the static 
planned dose GTVp by D99 and D60. 
 
  
Results: An overview of the E95BEV and E953D TE and GTV coverage is 
given in table 1. Overall, an average E95BEV of 3.5 mm and E953D of 5.6 
mm was found.  
The planned prescription dose to the PTV perifery resulted in a 
sufficient coverage (D99) of the GTV after convolution for 6 out of 7 
patients. For case 4, an underdosage of 5% to the GTV perifery was 
observed. On average, a dose loss of 7% to the GTV perifery was 
observed with respect to the planned dose intend. A boost to 60% of 
the target volume was maintained in all cases. 
In the current convolution approach, tracking errors in the BEV and 
tumor motion parallel to the CAX were considered to have an equal 
influence on the dose distribution. In reality, a photon dose 
distribution is considered more robust for target motion parallel to 
the CAX. Therefore, the current convolution possibly overestimates 
the influence of total 3D target motion around the isocenter during 
DTT, especially for dose reconstruction with large AP tumor motion, 
like case 4 of our study.  
To further improve DTT dose reconstruction, a more moderate 
handling of CAX target motion is needed during static dose 
convolution.  
 
  
Conclusions: An adequate target dose coverage was obtained after 
dose reconstruction for DTT on a gimballed linac. 
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Purpose/Objective: Respiratory motion monitoring is essential for 
gating or tracking based radiotherapy. A low-cost alternative to 
existing solutions is the Kinect surface sensor from Microsoft. The 
purpose of this study was to develop a reliable non-contact respiratory 
motion monitoring system using the Kinect. The system was calibrated 
with a 4D cone-beam CT (CBCT) acquired before treatment. 
Materials and Methods: The Kinect was mounted on the ceiling of one 
treatment room 2 meters away from the patient's breast surface. 
Depth images were captured at a rate of 30 Hz during the acquisition 
of a 4D cone-beam CT (CBCT) before treatment. The 4D CBCT is part 
of our clinical practice. The torso was segmented using the human 
body segmentation toolkit from the Microsoft Kinect SDK. We used a 
respiratory signal extraction algorithm (1) to detect local respiratory 
motion (Fig 1a). This algorithm uses a modified principal component 
analysis (PCA) on the depth values. The result is a set of components 
that indicate regions of motion. Respiratory signals from each 
combination of dominant components were next correlated with the 
respiratory signal extracted from the projection images of the 4D 
CBCT. The latter were extracted using the 'Amsterdam shroud' method 
(2). The components with the highest correlation were selected. 
The method was tested on 125 datasets of 11 lung cancer patients.  
Results: A single principal component was sufficient in 87.5% of the 
fractions to achieve a the highest correlation with the respiration 
signal from 'the Amsterdam Shroud'. The remaining 12.5% used two 
components. The average correlation coefficient between the motion 
monitoring system and respiratory signal from 4D CBCT used for 
calibration was 0.87 (range: 0.80 to 0.95). The largest source of 
limited correlation were short term phase shifts in the respiratory 
motion (Fig 1b). 
Conclusions: A contact-less respiratory motion system based on Kinect 
was developed to model respiratory motion. By calibrating the system 
to 4D-CBCT for each patient, a highly reliable extracted signal was 
obtained. 
(1) Wasza et al. 2012 Sparse Principal Axes Statistical Surface 
Deformation Models for Respiration Analysis and Classification 
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